Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Harvard Business School
QuintilesIMS
Julphar
UBS
Daiichi Sankyo
Boehringer Ingelheim
Fish and Richardson
Cipla

Generated: May 21, 2018

DrugPatentWatch Database Preview

TRIPROLIDINE HYDROCHLORIDE Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Triprolidine Hydrochloride patents expire, and when can generic versions of Triprolidine Hydrochloride launch?

Triprolidine Hydrochloride is a drug marketed by Alpharma Us Pharms, Halsey, Pharm Assoc, Vitarine, Watson Labs, Ivax Sub Teva Pharms, and Superpharm. and is included in seven NDAs.

The generic ingredient in TRIPROLIDINE HYDROCHLORIDE is pseudoephedrine hydrochloride; triprolidine hydrochloride. There are forty-nine drug master file entries for this compound. Additional details are available on the pseudoephedrine hydrochloride; triprolidine hydrochloride profile page.
Summary for TRIPROLIDINE HYDROCHLORIDE
Drug patent expirations by year for TRIPROLIDINE HYDROCHLORIDE
Synonyms for TRIPROLIDINE HYDROCHLORIDE
(E)-2-(3-(Pyrrolidin-1-yl)-1-(p-tolyl)prop-1-en-1-yl)pyridine hydrochloride
(E)-2-[1-(4-METHYLPHENYL)-3-(1-PYRROLIDINYL)-1-PROPENYL]PYRIDINE HYDROCHLORIDE
(E)-2-[3-(1-Pyrrolidinyl)-1-p-tolylpropenyl]pyridine hydrochloride
1-[(2E)-3-(4-methylphenyl)-3-(pyridin-2-yl)prop-2-en-1-yl]pyrrolidinium chloride
138T790
2-[(1E)-1-(4-Methylphenyl)-3-(1-pyrrolidinyl)-1-propen-1-yl]pyridine Hydrochloride
2-[(1E)-1-(4-methylphenyl)-3-(pyrrolidin-1-yl)prop-1-en-1-yl]pyridine hydrochloride
2-[(E)-1-(4-methylphenyl)-3-pyrrolidin-1-ylprop-1-enyl]pyridine hydrochloride
295 C 51
295C51
486-12-4 (Parent)
550-70-9
6138-79-0
AC-15905
AC1NWAR4
Actidilat
Actidilon
AK487173
AKOS015962154
AS-13971
C19H22N2.HCl
CCG-40331
CHEBI:84119
CHEMBL1200450
DTXSID10872513
EINECS 208-985-0
Entra
EU-0101130
FT-0082802
HE061157
HMS1568F06
HMS1921I07
LP01130
LS-131942
MFCD00039044
MLS000028751
MLS001148254
MLS002207213
MLS002222226
MolPort-003-666-303
NCGC00094397-01
NCGC00094397-02
NCGC00094397-03
NCGC00261815-01
NG7A104R3J
NSC-757361
NSC757361
Opera_ID_1214
Pharmakon1600-01500598
Prestwick_575
Pro-Actidil
Pro-Entra
Pyridine, 2-((1E)-1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propen-1-yl)-, hydrochloride (1:1)
Pyridine, 2-((1E)-1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propenyl)-, monohydrochloride
Pyridine, 2-(1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propenyl)-, monohydrochloride, (E)-
Pyridine, 2-(3-(1-pyrrolidinyl)-1-p-tolylpropenyl)-, monohydrochloride, (E)-
Pyridine, 2-[(1E)-1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propen-1-yl]-, hydrochloride (1:1)
SCHEMBL42145
SMR000058521
SPECTRUM1500598
SR-01000075292
SR-01000075292-1
T 6764
Tox21_501130
trans-1-(4-Methylphenyl)-1-(2-pyridyl)-3-pyrrolidinoprop-1-ene Hydrochloride
trans-2-(3-(1-Pyrrolidinyl)-1-p-tolylpropenyl)pyridine monohydrochloride
trans-2-[3-(1-Pyrrolidinyl)-1-(p-tolyl)propenyl]pyridine Hydrochloride
trans-2-[3-(1-Pyrrolidinyl)-1-p-tolylpropenyl]pyridine hydrochloride
trans-Triprolidine hydrochloride
triprolidine hydrochloride (anh.)
Triprolidine Hydrochloride (anhydrous)
Triprolidine hydrochloride anhydrous
Triprolidine hydrochloride, >=99%
Triprolidine hydrochloride, Sigma Reference Standard
Triprolidine Monohydrochloride
triprolidine monohydrochloride (anh.)
triprolidine monohydrochloride (anhydrous)
triprolidine monohydrochloride anhydrous
UNII-NG7A104R3J
V1639
Venen

US Patents and Regulatory Information for TRIPROLIDINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alpharma Us Pharms TRIPROLIDINE HYDROCHLORIDE triprolidine hydrochloride SYRUP;ORAL 085940-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Superpharm TRIPROLIDINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE pseudoephedrine hydrochloride; triprolidine hydrochloride TABLET;ORAL 088578-001 Feb 21, 1985 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Vitarine TRIPROLIDINE HYDROCHLORIDE triprolidine hydrochloride TABLET;ORAL 085610-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Halsey TRIPROLIDINE HYDROCHLORIDE triprolidine hydrochloride SYRUP;ORAL 088735-001 Jan 17, 1985 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
UBS
Farmers Insurance
Queensland Health
AstraZeneca
Colorcon
Cantor Fitzgerald
US Department of Justice
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.